Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001213900-26-046528
Filing Date
2026-04-22
Accepted
2026-04-22 13:48:30
Documents
1
Effectiveness Date
2026-04-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8815
  Complete submission text file 0001213900-26-046528.txt   10023
Mailing Address 1452 N US HIGHWAY 1 STE 123 ORMOND BEACH FL 32174
Business Address 1452 N US HIGHWAY 1 STE 123 ORMOND BEACH FL 32174 888-645-3947
Nok Therapeutics, Inc. (Filer) CIK: 0002038166 (see all company filings)

EIN.: 993344253 | State of Incorp.: FL
Type: D/A | Act: 33 | File No.: 021-562018 | Film No.: 26882806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)